Research Article

Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method

Table 2

Time courses of the visual and refractive outcomes between the pure ICL implantation and the traditional ICL implantation groups.

Preoperative periodPostoperative period value
1 day1 week3 months

LogMAR UDVA
Pure method1.283 ± 0.2260.008 ± 0.066−0.038 ± 0.067−0.038 ± 0.067
Traditional method1.23 ± 0.2190.07 ± 0.085−0.025 ± 0.084−0.042 ± 0.071
value

LogMAR BCVA
Pure method0.165 ± 0.103−0.01 ± 0.071−0.055 ± 0.064−0.058 ± 0.071
Traditional method0.182 ± 0.0980.048 ± 0.096−0.03 ± 0.082−0.058 ± 0.075
value

Spherical equivalent (D)
Pure method−11.306 ± 1.314−0.131 ± 0.253−0.156 ± 0.202−0.175 ± 0.206
Traditional method−11.638 ± 1.4310.044 ± 0.259−0.113 ± 0.16−0.144 ± 0.169
value

Note. P0: value of the difference between the preoperative and three-month values; P1: value of the difference between the pure ICL implantation and the traditional ICL implantation groups; : significant difference. LogMAR: logarithm of the minimal angle of resolution; UDVA: uncorrected distance visual acuity; BCVA: best-corrected distance visual acuity; D: diopter.